MIRRAGEN Biomatrix is a drug developed in the USA for the professional treatment of complex, chronic and difficult to heal wounds. Mirragen products have a number of advantages, in comparison with analogues, which can significantly reduce the time of treatment and wound healing of varying degrees of complexity and pathology.
The fibrous structure of the MIRRAGEN® matrix facilitates the absorption of liquid from the wound site and accelerates wound healing